ERBB2 and breast cancer: This is evidenced by the absence of tumor tissue in the biopsy of the affected skin.<h4>Lessons</h4>Breast cancer cutaneous metastasis, although rare, requires high vigilance, especially in the HER2-negative Luminal B subtype.